Arbutus Biopharma Corporation ABUS
3.66 USD -0.02 (-0.41%)
At closeNov 6, 2026, 4:50 PM EST
3.65 0.00 -0.14%
After hours · Nov 6, 4:50 PM ET
3.63 Day range 3.75
3.66 52-week range 5.22
- YTD
- -24.01%
- 1 year
- -17.68%
ABUS revenue history
Revenue is income from the company’s ordinary business activities.
14,083,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 14,083,000 | 7,912,000 | 128.21% |
| FY 2024 | 2024-12-31 | 6,171,000 | -11,970,000 | -65.98% |
| FY 2023 | 2023-12-31 | 18,141,000 | -20,878,000 | -53.51% |
| FY 2022 | 2022-12-31 | 39,019,000 | 28,031,000 | 255.11% |
| FY 2021 | 2021-12-31 | 10,988,000 | 4,074,000 | 58.92% |
| FY 2020 | 2020-12-31 | 6,914,000 | 903,000 | 15.02% |
| FY 2019 | 2019-12-31 | 6,011,000 | 66,000 | 1.11% |
| FY 2018 | 2018-12-31 | 5,945,000 | -4,755,000 | -44.44% |
| FY 2017 | 2017-12-31 | 10,700,000 | 9,209,000 | 617.64% |
| FY 2016 | 2016-12-31 | 1,491,000 | -21,785,000 | -93.59% |
| FY 2015 | 2015-12-31 | 23,276,000 | 8,323,000 | 55.66% |
| FY 2014 | 2014-12-31 | 14,953,000 | -512,000 | -3.31% |
| FY 2013 | 2013-12-31 | 15,465,000 | 1,360,000 | 9.64% |
| FY 2012 | 2012-12-31 | 14,105,000 | -2,706,590 | -16.10% |
| FY 2011 | 2011-12-31 | 16,811,590 | -4,543,149 | -21.27% |
| FY 2010 | 2010-12-31 | 21,354,739 | 6,926,323 | 48.00% |
| FY 2009 | 2009-12-31 | 14,428,416 | 2,696,840 | 22.99% |
| FY 2008 | 2008-12-31 | 11,731,576 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:30.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.